This summary is generated by an algorithm. If you find any mistakes, let us know.

Computer Medical Device North America

Huami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI Technology

Huami Corp. (NYSE: HMI) has invested $5 million in Hyperfine Research’s D round of funding, which closed on February 3, 2021.
– Huami’s mission is to connect health with technology, developing both consumer and industrial health technologies.
– The company believes its miniaturization engineering expertise dovetails with efforts to miniaturize medical imaging technology which can disrupt the locations, applications and costs of medical imaging.
– Hyperfine Research is pioneering MRI imaging with its portable Swoop system, which received FDA 510(K) clearance in August of 2020.

Information Technology North America Services

Rhino Health Raises $5 Million to Improve AI Workflows in Healthcare Using Federated Learning

– Rhino Health, a healthcare AI company, has raised $5m in a Seed financing round.
– The round was led by LionBird Ventures and includes Arkin Holdings and several angel investors who bring extensive experience across healthcare, imaging technology, software and biotech.
– Rhino Health is the first company to offer a Federated Learning platform for healthcare, which enables the development of AI models that can be trained on data where it lives.
– Using Federated Learning, Rhino Health eliminates the complexity, expense and risk of moving and managing huge volumes of data.
– Rhino Health co-founder and CEO Ittai Dayan, MD, previously co-led the EXAM Study with NVIDIA researchers, which utilized Federated Learning.
– NVIDIA is collaborating with Rhino Health to bring the benefits of Federated Learning into the clinical setting.

3D Printing Advanced Materials Building Material CAD Construction North America

Mighty Buildings Raises $40M In Series B Funding

– Mighty Buildings is a construction tech company applying automation and innovative new technologies to cut time and labor hours.
– The company raised $40m in Series B funding.
– The round was led by Khosla Ventures and co-led by Zeno Ventures, with participation from returning investors Bold Capital Partners, Core Innovation Capital, and Foundamental.
– New investors included ArcTern Ventures, Abies Ventures, Modern Venture Partners, Giant Ventures, MicroVentures, One Way Ventures, Polyvalent Capital and others.

Biopharma Biotechnology Health Care Medical North America Pharmaceutical

Day One Announces $130 Million Series B Financing to Accelerate New Targeted Cancer Treatments for Children

– Day One Biopharmaceuticals announced a $130m Series B financing round bringing total investment in the company to $190m.
– The round was led by RA Capital Management with participation from additional new investors Boxer Capital, BVF Partners L.P., Franklin Templeton, Janus Henderson Investors, Perceptive Advisors, funds and accounts advised by T. Rowe Price Associates, Inc., and Viking Global Investors.
– Existing investors Canaan, Access Biotechnology, and Atlas Venture also participated.
– Proceeds from the Series B financing will allow Day One to accelerate and expand its search and evaluation capabilities, support drug development efforts and continue advancing commercial launch plans for the Company’s lead program, DAY101.

Consulting North America Sports

U.S. Integrity Secures $1M in Seed Funding

– U.S. Integrity is a Las Vegas and New York-based technology and data-driven analytics company monitoring match-fixing, game manipulation and other unethical or illegal betting-related activity.
– The company secured $1m in seed funding.
– This round was led by the New York Angels with participation from Harvard Business School Alumni Angels of New York, existing investor SeventySix Capital, and several prominent financial service executives and entrepreneurs.
– Jeffrey Seltzer co-led the process for the New York Angels investment group and joined as a new Board Director.

Marketing & Advertising North America

MutualMarkets Announces $3.0M Seed Funding

– MutualMarkets, an AI platform enabling the brand economy, today announced its seed capital raise of $3 million.
– The capital will support the development and launch of its proprietary AI powered marketing technology.
– The round was led by Greycroft and Bessemer Venture Partners.
– Other investors include Peak Opportunity Partners, Michael Kempner (founder/CEO of MWWPR), Gerald S. Hobbes (Managing Director/Operating Partner, BV Investment Partners), Itzhak Fisher (founder, PEREG Ventures), and Russell Farscht (former Managing Director, Carlyle).
– MutualMarkets was founded by Alan and Eric Gould, founders of IAG Research and Peak Opportunity Partners.

Health Care Hospital Medical North America Wellness

Equip Raises $17 Million to Transform Eating Disorder Treatment

– Equip, a health tech company pioneering a program that virtually delivers evidence-based eating disorder treatment to families at home, today announced it has closed $13m in Series A financing, bringing its total funds raised to date to $17m.
– The Series A round was led by Optum Ventures, with participation from new investor .406 Ventures and existing investor F-Prime Capital, who led the company’s prior Seed round.
– Equip’s mission is to make gold-standard eating disorder treatment accessible to all people through Family-Based Treatment (FBT) – the standard of care which empowers families to help their loved ones through recovery.

Artificial Intelligence Europe Machine Learning Translation Service

Lengoo Raises USD 20M in Series B Funding

– Lengoo, a language tech company from Berlin, raised USD 20M in Series B funding.
– The round was led by Inkef Capital with existing investors Redalpine, Creathor Ventures, and Techstars also participating alongside angel investors Matthias Hilpert and Michael Schmitt.
– New investors also include Polipo Ventures and Volker Pyrtek (former CPO of Deutsche Telekom).
– The company intends to use the funds to accelerate global expansion and advance the development of their proprietary NMT framework for ultra customization of neural machine translation models for the professional use case.

Banking FinTech Information Technology North America Software

NYMBUS Raises $53 Million in Series C Funding Led by Insight Partners

– Nymbus raised a $53m Series C funding round.
– The round was led by Insight Partners.
– Nymbus will leverage the latest funds to empower financial institutions with expanded access to its unique GROW model which creates new digital revenue streams for banks and credit unions.
– Nymbus is a leading provider of banking technology solutions.
– Nymbus makes digital transformation quickly available to move any size financial institution forward.
– As part of this round, AJ Malhotra, Principal at Insight Partners, will join Managing Director Peter Sobiloff on the Nymbus Board of Directors.
– Jeffery Kendall will assume the title of CEO and Chairman of the Nymbus Board of Directors.
– Nymbus will continue broadening its solution and service offerings.

Artificial Intelligence Biotechnology Medical North America Therapeutics

BigHat Biosciences Raises $19 Million in Series A Funding to Advance Antibody Design and Development for Safer, More Effective Treatments

– BigHat Biosciences has raised $19m in Series A funding.
– The round was led by Andreessen Horowitz and included participation from prior investors 8VC, AME Cloud Ventures and Innovation Endeavors.
– BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform.
– BigHat has experienced rapid growth during its proof-of-concept stage, reaching significant corporate and scientific milestones in its first 15 months.
– BigHat’s wet lab is actively producing and characterizing antibodies at scale.
– BigHat’s cloud-based AI/ML platform improves designs each round by combining active learning with assay modeling of critical biophysical properties leading to the highest quality sequences.

1 2 3 28 29 30 31 32 33
Crunchbase icon

Content report

The following text will be sent to our editors: